Acquisitive Novartis bags PCSK9 player MedCo for $9.7B, setting up a flank attack on Sanofi, Regeneron and Amgen
The rumors were true.
Novartis has struck a deal to buy the Medicines Company $MDCO for $9.7 billion, putting it in the driver’s seat of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
